Tromethamine Usp, Disodium Edta Dihydrate

Verify with FDA CVM →

13 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
13
Total Reports
2
Deaths Reported
1540.0%
Death Rate

Active Ingredients

Tromethamine Usp, Disodium Edta Dihydrate

Administration Routes

UnknownAuricular (Otic)

Species Affected

Dog 9
Cat 4

Most Affected Breeds

Domestic Shorthair 2
Pit Bull 2
Beagle 1
Crossbred Feline/cat 1
Retriever - Labrador 1
Domestic Longhair 1
Collie - Border 1
Poodle - Toy 1
Bulldog 1
Havanese 1

Most Reported Reactions

Ataxia 3
Lack of efficacy - NOS 3
Anorexia 2
Horner's syndrome 2
Circling - neurological disorder (see also 'Behavioural disorders') 2
Vestibular disorder NOS 2
Head tilt - ear disorder 2
Ear discharge 2
Deafness 2
Neurological signs NOS 1
Adipsia 1
Third eyelid protrusion 1

Outcome Breakdown

Outcome Unknown
8 (61.5%)
Recovered/Normal
3 (23.1%)
Died
1 (7.7%)
Euthanized
1 (7.7%)

Data Summary

Metric Value
Total adverse event reports 13
Reports involving death 2
Case-fatality rate (reported events) 1540.0%
Distinct species in reports 2
Distinct breeds in reports 11
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Tromethamine Usp, Disodium Edta Dihydrate Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 13 adverse event reports referencing Tromethamine Usp, Disodium Edta Dihydrate, including 2 reports in which the animal died — a 1540.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Tromethamine Usp, Disodium Edta Dihydrate. Reported administration routes include Unknown, Auricular (Otic). These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Tromethamine Usp, Disodium Edta Dihydrate reports are Dog (9 reports), Cat (4 reports), with Dog accounting for the largest share. Within those species, Domestic Shorthair (2), Pit Bull (2), Beagle (1) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Tromethamine Usp, Disodium Edta Dihydrate are Ataxia (3), Lack of efficacy - NOS (3), Anorexia (2), Horner's syndrome (2). Of the 13 reports with a coded outcome, Outcome Unknown is the leading category at 61.5%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Tromethamine Usp, Disodium Edta Dihydrate.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial